Genmab CEO's pay increased 9.4% in 2022
![Jan van de Winkel, CEO of Genmab | Photo: Mik Eskestad/ERH](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13872494.ece/ALTERNATES/schema-16_9/doc7kbzimqui3svhxesmts.jpg)
Chief Executive Officer at Genmab Jan van de Winkel received an additional DKK 3.6m (USD 512,000) in compensation for this work in 2022, reveals the company’s remuneration report for the year.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Genmab keeps recruitment pace up
For subscribers
Genmab still has an appetite for acquisitions
For subscribers